Magnetic Resonance Imaging (MRI) Safety Information

whitePaper | August 4, 2022

The pressure to change is coming from all directions. Patients want care to be more personalized and convenient. Employees want the systems that support their work to function better.

whitePaper | March 22, 2023

The COVID-19 pandemic has renewed emphasis on innovations to support clinical trial operations. Traditional sites including hospitals and private practices were forced during the height of the pandemic to find novel ways to continue patient care.

whitePaper | March 6, 2023

Delivering exceptional member engagement experiences isn’t easy. Members expect seamless, convenient access to support and services in whatever channel they prefer.

whitePaper | June 16, 2022

Study feasibility is a fundamental contributor to the overall success of a clinical development program. However, selecting the right countries, sites and investigators and starting

whitePaper | June 24, 2023

A first-in-human (FIH) clinical trial is a significant milestone in the development of a potential new drug in that it will be the first opportunity for a drug development sponsor to evaluate the impact of their new chemical entity (NCE) or biologic in humans.

whitePaper | March 11, 2023

As innovation transforms the healthcare landscape, science and data are becoming the foundation for pharma to meet its obligations to patients and customers—and realize commercial opportunities.